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Abstract
Since the introduction of total mesorectal excision as 
the standard approach in mid and low rectal cancer, 
the incidence of local recurrence has sharply declined. 
Similar attention to surgical technique in colon cancer 
(CC) has resulted in the concept of complete mesocolic 
excision (CME), which consists of complete removal of 
the intact mesentery and high ligation of the vascular 
supply at its origin. Although renewed attention to 
meticulous surgical technique certainly has its merits, 
routine implementation of CME is currently unfounded. 
Firstly, in contrast to rectal cancer, local recurrence 
originating from an incompletely removed mesentery 
is rare in CC and usually a manifestation of systemic 
disease. Secondly, although CME may increase nodal 
counts and therefore staging accuracy, this is unlikely to 
affect survival since the observed relationship between 
nodal counts and outcome in CC is most probably 
not causal but confounded by a range of clinical 
variables. Thirdly, several lines of evidence suggest 
that metastasis to locoregional nodes occurs early and 
is a stochastic rather than a stepwise phenomenon in 
CC, in essence reflecting the tumor-host-metastasis 
relationship. Unsurprisingly, therefore, comparative 
studies in CC as well as in other digestive cancers have 
failed to demonstrate any survival benefit associated 
with extensive, additional or extra-mesenteric 
lymphadenectomy. Finally, routine implementation 
of CME may cause patient harm by longer operating 
times, major vascular damage and autonomic nerve 
injury. Therefore, data from randomized trials reporting 
relevant endpoints are required before CME can be 
recommended as a standard approach in CC surgery.
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
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Core tip: The extent of surgery in cancer of the colon is 
a matter of debate. Proponents of complete mesocolic 
excision (CME) argue that more extensive en bloc removal 
of the lymph node harboring mesentery may improve 
recurrence free survival. Here, we critically review the 
relevant clinical data and colorectal cancer biology and 
conclude that at present, routine implementation of 
a more extensive resection such as CME is unjustified 
outside the setting of controlled clinical trials.
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INTRODUCTION
Colon cancer (CC) is the third most common cancer in 
both men and women in the United States[1]. Surgery is 
the mainstay of  treatment of  non-metastatic CC. Since 
the nineteenth century, little has changed regarding the 
general surgical approaches used in CC. In contrast, the 
surgical treatment of  rectal cancer has seen considerable 
changes over the past three decades. Since the general 
adoption of  total mesorectal excision (TME) in mid 
and low rectal cancer, the formidable problem of  locally 
recurrent disease has been drastically reduced[2]. In 
addition, TME entails using embryological planes, which 
allows avoiding tumor spill, blood loss and autonomic 
nerve damage.
Recently, the concept of  complete excision of  the 
mesenteric envelope was adapted for colon cancer as 
complete mesocolic excision (CME)[3,4]. Two principles 
underlie CME. Firstly, the entire embryological mesocolon 
is separated from the parietal and retroperitoneal planes 
and removed in its entirety, avoiding breaching the 
surface of  the mesentery. Secondly, the feeding artery 
and draining vein(s) are ligated as close as possible to the 
main vascular trunk. As an example, when performing a 
right hemicolectomy, the ileocolic vein is ligated flush to 
the superior mesenteric vein rather than at a conveniently 
located more proximal location.
Proponents expect that standard adoption of  CME 
will result in a lower local recurrence rate and improved 
survival in CC[5,6]. Data from Erlangen suggest that 
routine application of  CME results in an excellent 
oncological outcome with 5 year cancer specific survival 
rates of  91.4% in stage Ⅱ and 70.2% in stage Ⅲ CC[3]. 
However, these benefits remain untested in comparative 
prospective trials and some have argued that, not 
unlike TME, CME really is a new nomenclature for a 
sound surgical approach for CC that many have been 
implemented for a long time in their practice[7]. More 
importantly, in view of  recent insights in colorectal 
cancer biology, the hypothesis that removing more lymph 
node containing mesentery is causally related to improved 
survival seems questionable[8]. 
Here, we critically review several aspects of  colon 
cancer biology and treatment that impact on the 
potential of  CME as a tool to improve the outcome for 
colon cancer patients. In essence, CME combines two 
imperatives: mobilization of  the intact mesentery along 
anatomical/embryological planes and high (proximal) 
vessel ligation in order to maximize nodal counts. Since 
most colorectal surgeons will agree that the former aspect 
constitutes nothing more than “good surgical practice”, 
we shall focus on the latter.
BIOLOGY OF NODAL SPREAD IN COLON 
CANCER
Historically, two models have been proposed to explain 
nodal spread of  epithelial cancer. In the first stepwise 
model championed by Halsted, nodal metastasis temporally 
and spatially precedes distant spread and invaded nodes 
are regarded as temporary “barriers” or “incubators” 
that eventually will seed cancer cells further down the 
lymphatic chain and/or into the systemic circulation[9]. 
Assuming this scenario is real, efforts at removing a 
maximal number of  (possibly) invaded nodes may prevent 
further tumor spread and result in a survival benefit. 
The parallel spread model proposed by Fisher considers 
distant metastasis to occur very early in the natural history 
of  the disease[10]. In this model, lymph node metastasis is 
seen as a marker of  the biological behavior and malignant 
potential of  the disease and efforts to remove affected 
nodes will not impact survival. Several lines of  evidence 
support the concept of  parallel progression in CC. 
Firstly, circulating tumor cells in the peripheral blood of  
colorectal cancer patients have been found in every stage 
of  the disease, independently of  methods and marker(s) 
used[11]. In a recent meta-analysis, molecular detection of  
tumor cells in regional nodes was found to predict disease 
recurrence and worse survival in node negative colorectal 
cancer[12]. Secondly, the estimated growth rates of  primary 
CC and liver metastases are comparable[13]. Given the 
average time frame between resection of  the primary and 
the appearance of  metastatic disease in CC, the growth 
rate of  metastases would need to be much higher if  the 
linear progression model was correct. Thirdly, genetic 
analysis at the chromosomal, genomic and DNA level 
demonstrates a striking disparity between primary CC 
cells, disseminated tumor cells and cells populating 
established metastases, suggesting early dissemination 
of  genetically less-advanced clones[14]. Finally, the linear, 
stepwise progression model of  lymphatic spread is 
incompatible with the observation that: (1) the number of  
invaded nodes is of  greater prognostic significance then 
their exact location in the mesentery; and (2) the location 
of  the first draining node when using sentinel mapping 
techniques is unpredictable and often at a considerable 
distance from the primary[15-17]. In addition, several studies 
have shown that the presence of  invaded nodes at the 
root of  the mesentery is associated with a significantly 
higher risk of  systemic spread and surgical removal of  
these nodes is therefore unlikely to affect the patient’s 
survival[18]. 
Taken together, these data suggest that lymphatic 
spread in CC is a stochastic rather than a stepwise 
phenomenon and may occur early during tumor 
progression. Nodal positivity reflects the tumor-host 
relationship and thus the biological behavior of  the 
disease. Therefore, surgical efforts at maximal nodal 
clearance are unlikely to affect the risk of  systemic 
spread.
NODAL COUNTS IN THE RESECTED 
SPECIMEN AND SURVIVAL IN COLON 
CANCER: CORRELATION VS CAUSALITY
Over the past decade, numerous clinical studies have 
reported a positive correlation between survival and the 
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lymph node count (LNC), i.e., the number of  lymph 
nodes examined by the pathologist[19-24]. In addition, the 
lymph node ratio, defined as the ratio of  the number of  
invaded nodes over the number of  examined nodes, is 
increasingly recognized as an independent prognosticator 
in stage Ⅲ disease[25]. 
It is therefore tempting to imply that a causal 
relationship exists between the removal of  mesenteric 
nodes and survival. In stage Ⅱ patients, increased 
survival may in theory be the result of  more extensive 
removal of  lymph nodes harboring isolated tumor cells 
or micrometastases, which could impact survival by 
causing either locoregional or systemic recurrence. The 
presence of  metastatic deposits in regional lymph nodes 
was recently shown to be an adverse prognostic factor in 
node-negative CRC[12]. Similarly, in stage Ⅲ, removal of  
grossly invaded nodes could prevent either locoregional 
recurrence or further systemic tumor spread. In reality, 
however, the relationship between LNC and survival is 
confounded by a range of  clinicopathological variables 
(Table 1) and a real therapeutic effect of  removing 
mesenteric nodes seems to play a minimal, if  any, role[26]. 
Several authors have compared limited with extensive 
surgery for CC (Table 2). In a French multicenter 
prospective trial, Rouffet et al[27] randomly allocated 260 
CC patients to either a left segmental colectomy or a left 
hemicolectomy. Only the length of  tumor-free margins 
of  colon removed was significantly greater after left 
hemicolectomy. Survival in both groups was, however, 
similar. In a retrospective single center study, Tagliacozzo 
et al[28] compared extended mesenteric excision (up 
to the origin of  the mesenteric trunk combined with 
retropancreatic lymphadenectomy) with standard right 
hemicolectomy. Although radical resection resulted in a 
significantly higher LNC, no difference in the number 
of  positive nodes or survival was found. Similarly, a 
prospective single center trial by Tentes et al[29] compared 
periaortic lymph node resection for left-sided CC with 
conventional surgery in 124 patients. Again, despite 
a significantly higher LNC after radical resection, no 
significant difference in number of  involved nodes or 
survival was noted, although improved survival in stage 
Ⅲ patients was found after radical resection (P = 0.04). 
A two-center study reported by West et al[30] observed 
a greater LNC after CME compared to conventional 
hemicolectomy. This observation was not associated with 
a difference in the rate of  involved nodes. Survival data 
were not reported in this study. A running prospective, 
non-randomized, single-center study will assess both 
procedures in terms of  overall survival and disease-free 
survival (NCT01724775). Hashiguchi et al[31] recently 
reported retrospective data on 914 T2-T4 CC patients 
in whom lymph nodes were anatomically mapped 
and classified as horizontal nodes (epicolic/paracolic 
nodes), mesocolic nodes and nodes at the origin of  the 
main arterial trunk. They found that resection of  main 
trunk nodes did not improve either staging accuracy 
or survival compared to resection of  pericolic and 
mesocolic nodes alone. Similarly, Ikeda et al[32] found no 
difference in survival of  separate cohorts of  stage Ⅱ and 
stage Ⅲ rectosigmoid cancer, whether or not the main 
trunk (“apical”) nodes were prophylactically resected. 
In addition, a recent meta-analysis demonstrated that 
performing a high arterial ligation in CC (which may be 
assumed to result in removal of  apical nodes) does not 
improve overall survival (OR 0.45-2.22)[33]. Together, 
these data fail to demonstrate that extensive surgery or 
extramesenteric lymphadenectomy improves survival 
in CC, which argues against a surgical therapeutic effect 
as an explanation of  the observed relationship between 
LNCs and survival.
LOCAL RECURRENCE IN COLON CANCER
Historically, local recurrence has been a frequent and 
dreaded manifestation of  disease recurrence after 
rectal cancer surgery. This propensity to recur locally 
is explained by the anatomical confinement of  the 
(meso)rectum by the bony pelvis, bladder and genital 
organs and by the fact that the mesorectum may harbor 
tumor deposits several centimeters distally from the lower 
margin of  the rectal cancer itself[34]. In colon cancer, 
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Table 1  Variables confounding the association between nodal count and survival in colorectal cancer
Confounding variables Effect on LNC
Patient characteristics ↑Age, ↓socioeconomic status, non-Caucasian race ↓
gender, body mass index ?
Tumor characteristics ↑Tumor diameter, T stage, overall cancer stage, lymphocytic infiltration, MSI-H phenotype ↑
↑Tumor grade ↓
Mucinous differentiation, lymphovascular and perineural invasion ?
Surgical factors Open vs minimally invasive resection None
Colorectal vs general surgeons, advanced fellowship training ↑
Surgeon volume ?
Institutional factors High-volume centers, teaching hospitals, significant CC surgical practice, academic pathology laboratories ↑
Preoperative radiochemotherapy for rectal cancer ↓
Factors related to 
pathology examination
Xylene/alcohol fat clearance, embedding of the entire mesentery vs traditional dissection, ex vivo intra-arterial 
methylene blue injection, tattooing of neoplasms during colonoscopy, pathologists interested in CRC, use of a 
standardized protocol to evaluate CC specimens
↑
LNC: Lymph node count; CC: Colon cancer; CRC: Colorectal cancer; MSI: Microsatellite instability. 
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plane resection, while a small (but statistically significant) 
increase was noted in LNC (from mean 24.5 to 26.2, P = 
0.009) after the introduction of  CME. None of  the above 
studies has reported recurrence or survival data. In a 
recent retrospective study from Norway, CC survival data 
were compared between one hospital that used the CME 
approach and two other centers that used the ‘standard’ 
approach (termed D2 resection by the authors)[40]. They 
observed a better 3 year overall survival (88.1% vs 79.0%, 
P = 0.003) and disease-free survival (82.1% vs 74.3%, P 
= 0.026) in the CME patient group, while cancer-specific 
survival was 95.2% in the CME group vs 90.5% in the 
standard group (P = 0.067). Age, operative technique 
and T category were significant in Cox multivariate 
regression of  overall and disease-free survival. Galizia et 
al[41] compared CC recurrence and survival data before 
and after adoption of  CME (since 2008) in the same 
Italian center. Interestingly, local recurrence developed 
in none of  the CME but in 21% of  the standard group, 
while distant metastasis occurred with similar frequency 
(13.3% and 13.7%, respectively). There were, however, 
significantly more early stage cancers in the CME 
group. Although the data from the above two studies 
are thought provoking, it is clear that any conclusions 
regarding the survival benefit, if  any, from CME should 
be drawn with caution due to the multiple possible causes 
of  bias. 
Although CME seems to be a safe procedure in expert 
hands, it should be noted that high ligation of  vascular 
trunks may considerably increase the risk of  bleeding. 
Specifically, the technical demands of  (laparoscopic) right 
hemicolectomy, a procedure commonly considered to be 
of  moderate difficulty and often entrusted to surgeons in 
training, rise sharply with CME and an increased risk of  
troublesome bleeding caused by damage to the superior 
mesenteric vein during laparoscopic right hemicolectomy 
should be anticipated. Similarly, flush ligation of  the 
inferior mesenteric artery when performing a left colon 
resection may cause severe damage to the sympathetic 
autonomic nerve supply to the pelvic organs.
CONCLUSION
The introduction of  the CME concept certainly has the 
merit of  highlighting the importance of  sound judgment 
and precise technique in the surgical management of  
colon cancer. However, not unlike the concept of  
TME in rectal cancer, many will argue that mesocolic 
resection, preserving the integrity of  the mesentery that 
is mobilized along embryological planes, constitutes 
nothing more than good surgical practice and has 
been the standard operative approach of  colorectal 
surgeons. The second tenet of  CME, high ligation of  the 
supplying vessels aimed at maximizing nodal clearance 
and preventing local recurrence, is currently scientifically 
and ethically unfounded. Although “complete”, “total” 
and “radical” are cherished epithets in surgical jargon, 
the reality is that no benefit has been proven in any 
of  the gastrointestinal cancers of  extensive surgery 
and/or extra-mesenteric lymphadenectomy. As has 
been apparent since the time of  Halsted, the future of  
surgical oncology lies in more precise, imaging based, 
less invasive and less morbid surgery, performed as 
an integral component of  a multimodal approach and 
based on the most recent insights in cancer biology. In 
colon cancer, several comparative clinical studies have 
confirmed that “high tie” ligation, extensive vs segmental 
resection, or extensive lymphadenectomy do not improve 
outcome. Although CME may increase nodal counts 
and therefore improve staging accuracy, any survival 
benefit is very unlikely since the relationship that is often 
observed between nodal counts and survival in CC is 
almost certainly not causal but confounded by a range 
of  clinical, pathological and provider related factors. 
Finally, routine implementation of  CME carries the risk 
of  patient harm due to longer operating times, vascular 
damage and autonomous nerve damage. Therefore, in 
the absence of  data from prospective randomized trials 
with relevant clinical endpoints (i.e., disease free survival 
rather than nodal counts), CME should be considered 
investigational. The time is right to organize such a trial 
as a matter of  priority.
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